{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:38:51Z","timestamp":1784137131113,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multifocal fibrosing thyroiditis (MFT) is an enigmatic entity, characterized by multiple fibrotic scar-like lesions with a paucicellular fibrotic center surrounded by a cellular peripheral area with reactive-appearing follicular cell atypia and variable chronic inflammation. Although poorly recognized and likely underreported in surgical pathology, the entity is considered rare with only 65 cases to date\u2013including the current one reported to expand on the preoperative findings of this under-recognized entity. The average age of the patients is 46.8\u00a0years (range 15\u201371\u00a0years), 94% are female, with female to male ratio of 15:1. Individual MFT lesions typically have a superficial location. The average number of fibrotic lesions is 15.4 (range 2\u201351 per MFT case). Their average size is 3.1\u00a0mm (range 0.4\u201315.1). MFT is a disorder of diseased thyroids, typically found postoperatively in glands removed for other reasons, such as chronic lymphocytic\/Hashimoto thyroiditis (32.3%), follicular nodular disease (nodular hyperplasia) (30.1%), hyperthyroidism\/diffuse hyperplasia (Graves disease) (9.2%). Intriguing is the association with papillary thyroid carcinoma\u2013present in 38.5% of MFT cases, and particularly with sub-centimetric and multifocal papillary thyroid carcinoma, with which MFT can be confused. Cases where MFT is the only thyroid pathology (7.7%) can be preoperatively mistaken for papillary thyroid carcinoma, due to worrisome ultrasound (US) and cytologic features, both of which are here documented for the first time as a component of this article. Wider recognition of MFT and of its cytologic and ultrasound features at preoperative evaluation may reduce unnecessary thyroidectomies.<\/jats:p>","DOI":"10.1007\/s12022-022-09726-0","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T08:05:56Z","timestamp":1657613156000},"page":"335-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma"],"prefix":"10.1007","volume":"33","author":[{"given":"Agnese","family":"Orsatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Chiarucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Cremonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Fornelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Amorosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Maloberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"de Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"9726_CR1","unstructured":"Rosai J, Carcangiu M, DeLellis R. Atlas of tumor pathology, third series, fascicle 5. Washington, DC: Armed Forces Institute of Pathology and American Registry of Pathology. Washington, DC, 1990; 310\u2013311."},{"key":"9726_CR2","doi-asserted-by":"crossref","unstructured":"Poli F, Trezzi R, Fellegara G, Rosai J. Images in pathology. Multifocal sclerosing thyroiditis. Int J Surg Pathol 17: 144, 2009.","DOI":"10.1177\/1066896908329800"},{"key":"9726_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12022-013-9289-0","volume":"25","author":"R Frank","year":"2014","unstructured":"Frank R, Baloch ZW, Gentile C, Watt CD, LiVolsi VA. Multifocal fibrosing thyroiditis and its association with papillary thyroid carcinoma using BRAF pyrosequencing. Endocr Pathol 25: 236-240, 2014.","journal-title":"Endocr Pathol"},{"key":"9726_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/PAS.0000000000000337","volume":"39","author":"G Fellegara","year":"2015","unstructured":"Fellegara G, Rosai J. Multifocal fibrosing thyroiditis: report of 55 cases of a poorly recognized entity. Am J Surg Pathol 39: 416-424, 2015.","journal-title":"Am J Surg Pathol"},{"key":"9726_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/PAS.0000000000000431","volume":"39","author":"G Fellegara","year":"2015","unstructured":"Fellegara G, Rosai J. Gross appearance of multifocal fibrosing thyroiditis. Am J Surg Pathol 39: 870, 2015.","journal-title":"Am J Surg Pathol"},{"key":"9726_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000478927","volume":"6","author":"G Russ","year":"2017","unstructured":"Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J 6: 225-237, 2017.","journal-title":"Eur Thyroid J"},{"key":"9726_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26: 1-133, 2016.","journal-title":"Thyroid"},{"key":"9726_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40618-014-0062-0","volume":"37","author":"F Nardi","year":"2014","unstructured":"Nardi F, Basolo F, Crescenzi A et al. Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest 37: 593-599, 2014.","journal-title":"J Endocrinol Invest"},{"key":"9726_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12022-019-09602-4","volume":"31","author":"P Trimboli","year":"2020","unstructured":"Trimboli P, Fulciniti F, Paone G, et al. Risk of malignancy (ROM) of thyroid FNA diagnosed as suspicious for malignancy or malignant: an institutional experience with systematic review and meta-analysis of literature. Endocr Pathol. 31: 52-56, 2020.","journal-title":"Endocr Pathol."},{"key":"9726_CR10","doi-asserted-by":"crossref","unstructured":"de Biase D, Acquaviva G, Visani M et al. Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel. Diagnostics (Basel) 10, 2020.","DOI":"10.3390\/diagnostics10040250"},{"key":"9726_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/1735-1995.183986","volume":"21","author":"S Erdogan-Durmus","year":"2016","unstructured":"Erdogan-Durmus S, Ozcan D, Yarikkaya E, Kurt A, Arslan A. CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions. J Res Med Sci 21: 49, 2016.","journal-title":"J Res Med Sci"},{"key":"9726_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/his.13380","volume":"72","author":"G Acquaviva","year":"2018","unstructured":"Acquaviva G, Visani M, Repaci A et al. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance. Histopathology 72: 6-31, 2018.","journal-title":"Histopathology"},{"key":"9726_CR13","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.21037\/gs-20-429","volume":"9","author":"S Canberk","year":"2020","unstructured":"Canberk S. Precursor and borderline lesions of the thyroid (indolent lesions of epithelial origin): from theory to practice. Gland Surg 9: 1724-1734, 2020.","journal-title":"Gland Surg"},{"key":"9726_CR14","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/S0002-9440(10)61164-9","volume":"160","author":"A Fusco","year":"2002","unstructured":"Fusco A, Chiappetta G, Hui P et al. Assessment of RET\/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol 160: 2157-2167, 2002.","journal-title":"Am J Pathol"},{"key":"9726_CR15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1089\/thy.2016.0605","volume":"27","author":"R Giannini","year":"2017","unstructured":"Giannini R, Ugolini C, Poma AM et al. Identification of two distinct molecular subtypes of non-invasive follicular neoplasm with papillary-like nuclear features by digital RNA counting. Thyroid 27: 1267-1276, 2017.","journal-title":"Thyroid"},{"key":"9726_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13000-015-0262-8","volume":"10","author":"M Lamba Saini","year":"2015","unstructured":"Lamba Saini M, Weynand B, Rahier J, Mourad M, Hamoir M, Marbaix E. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential. Diagn Pathol 10: 32, 2015.","journal-title":"Diagn Pathol"},{"key":"9726_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAT.0b013e32835f45c5","volume":"45","author":"O Mete","year":"2013","unstructured":"Mete O, Asa SL. Precursor lesions of endocrine system neoplasms. Pathology 45: 316-330, 2013.","journal-title":"Pathology"},{"key":"9726_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00428-013-1397-1","volume":"462","author":"MH Chui","year":"2013","unstructured":"Chui MH, Cassol CA, Asa SL, Mete O. Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in chronic lymphocytic thyroiditis. Virchows Arch 462: 557-563, 2013.","journal-title":"Virchows Arch"},{"key":"9726_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12022-021-09679-w","volume":"32","author":"I Kholov\u00e1","year":"2021","unstructured":"Kholov\u00e1 I, Kalfert D, Lintusaari J, Rajakorpi E, Ludv\u00edkov\u00e1 M. Follicular epithelial dysplasia as Hashimoto thyroiditis-related atypia: a Series of 91 Specimens. Endocr Pathol 32: 368-374, 2021.","journal-title":"Endocr Pathol"},{"key":"9726_CR20","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1210\/jc.2006-0240","volume":"91","author":"KJ Rhoden","year":"2006","unstructured":"Rhoden KJ, Unger K, Salvatore G et al. RET\/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 91: 2414-2423, 2006.","journal-title":"J Clin Endocrinol Metab"},{"key":"9726_CR21","doi-asserted-by":"crossref","unstructured":"Acquaviva G, de Biase D, Diquigiovanni C et al. BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: a search for the early molecular events associated with tumor development. Cancers (Basel) 12, 2020.","DOI":"10.3390\/cancers12020430"},{"key":"9726_CR22","unstructured":"Hazard JB. Small papillary carcinoma of the thyroid. A study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest 9: 86\u201397, 1960."},{"key":"9726_CR23","doi-asserted-by":"crossref","unstructured":"Hazard JB, Crile G, Jr., Dempsey WS. Nonencapsulated sclerosing tumors of the thyroid. J Clin Endocrinol Metab 9: 1216\u20131231, illust, 1949.","DOI":"10.1210\/jcem-9-11-1216"},{"key":"9726_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/1097-0142(1955)8:4<701::AID-CNCR2820080412>3.0.CO;2-V","volume":"8","author":"GH Klinck","year":"1955","unstructured":"Klinck GH, Winship T. Occult sclerosing carcinoma of the thyroid. Cancer 8: 701-706, 1955.","journal-title":"Cancer"},{"key":"9726_CR25","doi-asserted-by":"crossref","unstructured":"Tallini G, De Leo A, Repaci A et al. Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification. Cancers (Basel) 12, 2020.","DOI":"10.3390\/cancers12010246"},{"key":"9726_CR26","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/cncr.26425","volume":"118","author":"LA Niemeier","year":"2012","unstructured":"Niemeier LA, Kuffner Akatsu H, Song C et al. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer 118: 2069-2077, 2012.","journal-title":"Cancer"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-022-09726-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T04:29:32Z","timestamp":1661574572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-022-09726-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["9726"],"URL":"https:\/\/doi.org\/10.1007\/s12022-022-09726-0","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"21 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All information regarding the human material was managed by using anonymous numerical codes, and the study was carried out in accordance with the ethical principles of the Declaration of Helsinki ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The patient has provided informed consent to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of Interest"}}]}}